Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions (3D)

This study has been completed.

Sponsor:

Information provided by:

Cordis Corporation

ClinicalTrials.gov Identifier:

NCT00233714

First received: October 4, 2005

Last updated: November 17, 2009

Last verified: November 2009

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	November 2009
Primary Completion Date:	July 2004 (Final data collection date for primary outcome measure)

Publications:

Costa R, Sousa JE, et al. The radomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesions. EuroInterv.2006;2:295-301

Hur SH, Ako J, Shimada Y, Tsujino I, Hassan AH, Abizaid A, Shiran A, Lewis BS, Guagliumi G, Cohen SA, Honda Y, Fitzgerald PJ, Sousa JE. Two-year intravascular ultrasound observations in diabetic patients treated with single and double dose sirolimus-eluting stents: results of the double dose diabetes (3D) study. J Invasive Cardiol. 2008 Aug;20(8):411-6.

To Top